PXD057519 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | p-FADD-CD8+T cell axis determines hepatocellular carcinoma response to immune checkpoint inhibitors |
Description | The heterogenicity of hepatocellular carcinoma (HCC) remains a key obstacle in turning the majority of ‘immune-cold’ tumors ‘hot’ for effective immune checkpoint inhibitors (ICIs). Through analyzing the naturally-existed ‘hot’ HCC variants, we identified fas-associated death domain (FADD) as a key molecule upregulated in patients with dense tumor-filtrating CD8+T cells and better response to ICIs. Apart from the canonical role in apoptosis pathway, our data showed that CRISPR knockout of hepatoma-intrinsic Fadd led to increased tumor weights in immunocompetent but not immunodeficient mice, accompanied with decreased numbers and IFN-γ/TNF-ɑ production of tumor-filtrating CD8+T cells. Mechanistically, phosphorylated FADD translocated into cell nucleus, where it interacted with Sam68 to upregulate NF-κB transcription of CCL5, thereby promoted CD8+T cell tumor infiltration. Interestingly, anti-PD1 triggered FADD phosphorylation by CD8+T cell-derived IFN-γ/TNF-ɑ in ICI-sensitive, but not resistant tumors. Sequential FADD activation through genetic or pharmacologic approaches to orchestrate p-FADD-CD8+T cell axis therefore overcame ICI resistance in ICI-resistant orthotopic and spontaneous HCC mouse models in vivo. Taken together, our findings may provide insights into the combinatory immunotherapy approaches for the majority of HCC patients in the future. |
HostingRepository | PRIDE |
AnnounceDate | 2025-07-07 |
AnnouncementXML | Submission_2025-07-06_23:14:01.645.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Thomas Ting Hei Chan |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | acetylated residue; monohydroxylated residue; iodoacetamide derivatized residue |
Instrument | Q Exactive HF-X |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-11-05 00:21:22 | ID requested | |
⏵ 1 | 2025-07-06 23:14:02 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
ProteomeXchange project tag: Human Proteome Project |
submitter keyword: HCC,FADD, Hepg2 |
Contact List
Jingying Zhou |
contact affiliation | School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR |
contact email | zhoujy@cuhk.edu.hk |
lab head | |
Thomas Ting Hei Chan |
contact affiliation | School of Biomedical Sciences, The Chinese University of Hong Kong |
contact email | tingheithomas@link.cuhk.edu.hk |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/07/PXD057519 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD057519
- Label: PRIDE project
- Name: p-FADD-CD8+T cell axis determines hepatocellular carcinoma response to immune checkpoint inhibitors